Limited value of myeloablative therapy for late multiple myeloma
Data up to Jan 2025
Total Citations Per Year
Abstract
References (14)
A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival
1975 • 3,051 citations
High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
1987 • 797 citations
High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma
1987 • 270 citations
High Serum Lactate Dehydrogenase Level as a Marker for Drug Resistance and Short Survival in Multiple Myeloma
1991 • 203 citations
The growth fraction of human myeloma cells
1981 • 139 citations
Double-intensive therapy in high-risk multiple myeloma
1992 • 133 citations
Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factors
1990 • 130 citations
Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma
1993 • 128 citations
Prognostic implications of tumor cell DNA and RNA content in multiple myeloma
1985 • 113 citations
Myeloma protein kinetics following chemotherapy
1982 • 94 citations
Cyclophosphamide and etoposide therapy with GM‐CSF for VAD‐resistant multiple myeloma
1993 • 43 citations
Colony growth and self renewal of plasma cell precursors in multiple myeloma.
1985 • 37 citations
The Role of Autologous Blood Stem Cells in Support of High-dose Therapy for Multiple Myeloma
1992 • 30 citations
α-Interferon Combination Therapy of Resistant Myeloma
1991 • 26 citations